HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A swine model of acute thrombocytopenia with prolonged bleeding time produced by busulfan.

Abstract
Animal models of thrombocytopenia are indispensable for evaluating the in vivo efficacy of hemostatic agents, cryopreserved platelets, and artificial platelets, but no large animal models are available. In this study, we generated a swine model of acute thrombocytopenia with prolonged bleeding times by administering the chemotherapeutic drug busulfan. First, we tested multiple doses of busulfan (4, 6, and 8 mg/kg) in pigs, and found that 6 mg/kg of busulfan is an optimal dose for producing a safe and moderate thrombocytopenia, with a platelet count of less than 30,000/µl. The pigs administered 6 mg/kg of busulfan (n=8) reached half their initial counts at day 7, counts below 30,000/µl at day 12, and their nadirs at day 15 (on average). The minimal platelet count was 14,000/µl. With this dose of busulfan (6 mg/kg), bleeding times were significantly prolonged in addition to the decrease in platelet counts (r=-0.63, P<0.01), while there were no cases of apparent hemorrhage. White blood cell counts were maintained at over 5,000/µl, and there were no infections or other adverse events including anemia or appetite or body weight loss. All pigs were sacrificed on day 16, with subsequent examination showing a significant reduction in cellularity and colony-forming units in the bone marrow, indicating that thrombocytopenia was the result of myelosuppression. In summary, administration with 6 mg/kg of busulfan induces safe and moderate thrombocytopenia with a prolonged bleeding time in swine.
AuthorsTomoyuki Abe, Shota Kono, Takahiro Ohnuki, Shuji Hishikawa, Satoshi Kunita, Yutaka Hanazono
JournalExperimental animals (Exp Anim) Vol. 65 Issue 4 Pg. 345-351 (Nov 01 2016) ISSN: 1881-7122 [Electronic] Japan
PMID27333841 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Busulfan
Topics
  • Acute Disease
  • Animals
  • Antineoplastic Agents, Alkylating (adverse effects)
  • Bleeding Time
  • Busulfan (adverse effects)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Hematologic Tests
  • Humans
  • Male
  • Swine
  • Swine, Miniature
  • Thrombocytopenia (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: